# Astellas Pharma to acquire Iota Biosciences for bioelectronics technology

Astellas Pharma Inc. announced it will acquire Iota Biosciences, Inc., a start-up company with unique ultrasonic-powered bioelectronic devices technology. The acquisition is expected to accelerate Astellas' Rx+ business by acquiring innovative technology for ultra-small implantable medical devices.

- Type: Acquisition
- Announced: 2020-10-15
- Where: Berkeley, California, United States
- Status: announced
- Products: ultrasonic-powered bioelectronic implantable medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Astellas Pharma Inc.](https://endata.com/companies/35227.md) (acquirer)
- [Iota Biosciences](https://endata.com/companies/50527.md) (target)

## Sources

- [newsroom.astellas.com](https://newsroom.astellas.com/2020-10-15-Astellas-to-Acquire-iota-Biosciences), 2020-10-15: "Through the acquisition of iota, Astellas will acquire iota's unique bioelectronics technology and world-class talent."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.